Bullseye Asset Management’s OptimizeRx OPRX Stock Holding History

Bullseye Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	226,527 +20,000	+10%	+$186K	0.82%	50
2025 Q4	$2.53M	Hold	206,527	–	–	1.36%	33
2025 Q3	$4.23M	Hold	206,527	–	–	2.22%	13
2025 Q2	$2.79M	Hold	206,527	–	–	1.39%	32
2025 Q1	$1.79M	Buy	206,527 +5,000	+2%	+$30.6K	0.97%	38
2024 Q4	$980K	Sell	201,527 -12,519	-6%	-$70K	0.46%	54
2024 Q3	$1.65M	Buy	214,046 +76,458	+56%	+$680K	0.76%	46
2024 Q2	$1.38M	Buy	137,588 +15,000	+12%	+$165K	0.67%	48
2024 Q1	$1.49M	Hold	122,588	–	–	0.7%	50
2023 Q4	$1.75M	Hold	122,588	–	–	0.84%	49
2023 Q3	$953K	Hold	122,588	–	–	0.53%	56
2023 Q2	$1.75M	Hold	122,588	–	–	0.88%	44
2023 Q1	$1.79M	Hold	122,588	–	–	0.91%	46
2022 Q4	$2.06M	Hold	122,588	–	–	1.11%	40
2022 Q3	$1.82M	Sell	122,588 -1,498	-1%	-$29.6K	1.06%	43
2022 Q2	$3.4M	Buy	124,086 +336	+0.3%	+$9.96K	1.92%	18
2022 Q1	$4.67M	Hold	123,750	–	–	2.15%	13
2021 Q4	$7.61M	Sell	123,750 -63,292	-34%	-$4.8M	3.02%	3
2021 Q3	$16M	Sell	187,042 -35,670	-16%	-$2.24M	5.55%	1
2021 Q2	$13.8M	Hold	222,712	–	–	4.64%	1
2021 Q1	$10.9M	Hold	222,712	–	–	4.06%	1
2020 Q4	$6.94M	Buy	222,712 +13,382	+6%	+$328K	2.59%	6
2020 Q3	$4.37M	Sell	209,330 -131	-0.1%	-$2.25K	1.99%	12
2020 Q2	$2.73M	Buy	209,461 +80,563	+63%	+$876K	1.46%	24
2020 Q1	$1.17M	Buy	128,898 +17,811	+16%	+$169K	1.39%	26
2019 Q4	$1.14M	Buy	+111,087	New	+$1.26M	1.1%	38

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bullseye Asset Management's OPRX Position: Q1 2026 in Review

Bullseye Asset Management increased its OptimizeRx (OPRX) stake by 9.7% in Q1 2026, buying an estimated $186K and bringing the position to 226,527 shares worth $1.42M. The position accounts for 0.82% of the portfolio, ranked #50.

Bullseye Asset Management first reported a position in OPRX in Q4 2019 and has held it in 26 quarters since. The position peaked at $16M in Q3 2021. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Bullseye Asset Management held 226,527 shares of OptimizeRx worth $1.42M as of Q1 2026.
Bullseye Asset Management bought 20,000 OptimizeRx shares in Q1 2026, an estimated $186K.
OptimizeRx made up 0.82% of Bullseye Asset Management's portfolio in Q1 2026, its #50 holding.
Bullseye Asset Management first reported a position in OptimizeRx in Q4 2019 and has held it in 26 quarters since.
Bullseye Asset Management's OptimizeRx position peaked at $16M in Q3 2021.
127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Bullseye Asset Management's 13F filing for Q1 2026, filed 14 May 2026.